These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 18157525)

  • 41. Smoking impact on CYP1A2 activity in a group of patients with schizophrenia.
    Bozikas VP; Papakosta M; Niopas I; Karavatos A; Mirtsou-Fidani V
    Eur Neuropsychopharmacol; 2004 Jan; 14(1):39-44. PubMed ID: 14659985
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Caffeine as a probe for CYP1A2 activity: potential influence of renal factors on urinary phenotypic trait measurements.
    Tang BK; Zhou Y; Kadar D; Kalow W
    Pharmacogenetics; 1994 Jun; 4(3):117-24. PubMed ID: 7920691
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Estimation of cytochrome P-450 CYP1A2 activity in 863 healthy Caucasians using a saliva-based caffeine test.
    Tantcheva-Poór I; Zaigler M; Rietbrock S; Fuhr U
    Pharmacogenetics; 1999 Apr; 9(2):131-44. PubMed ID: 10376760
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Impact of long-term ethanol consumption on CYP1A2 activity.
    Rizzo N; Hispard E; Dolbeault S; Dally S; Leverge R; Girre C
    Clin Pharmacol Ther; 1997 Nov; 62(5):505-9. PubMed ID: 9390106
    [TBL] [Abstract][Full Text] [Related]  

  • 45. CYP2C19 activity comparison between Swedes and Koreans: effect of genotype, sex, oral contraceptive use, and smoking.
    Ramsjö M; Aklillu E; Bohman L; Ingelman-Sundberg M; Roh HK; Bertilsson L
    Eur J Clin Pharmacol; 2010 Sep; 66(9):871-7. PubMed ID: 20499227
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Evaluation of the impact of CYP1A2 induction by charbroiled meal on metabolic phenotype.
    Anumu George J; Adehin A; Bolaji OO
    Clin Nutr ESPEN; 2018 Oct; 27():96-99. PubMed ID: 30144900
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Assessment of CYP1A2 enzyme activity in relation to type-2 diabetes and habitual caffeine intake.
    Urry E; Jetter A; Landolt HP
    Nutr Metab (Lond); 2016; 13():66. PubMed ID: 27713762
    [TBL] [Abstract][Full Text] [Related]  

  • 48. The influence of CYP1A2 genotype in the blood pressure response to caffeine ingestion is affected by physical activity status and caffeine consumption level.
    Soares RN; Schneider A; Valle SC; Schenkel PC
    Vascul Pharmacol; 2018 Jul; 106():67-73. PubMed ID: 29522901
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of caffeine-containing versus decaffeinated coffee on serum clozapine concentrations in hospitalised patients.
    Raaska K; Raitasuo V; Laitila J; Neuvonen PJ
    Basic Clin Pharmacol Toxicol; 2004 Jan; 94(1):13-8. PubMed ID: 14725610
    [TBL] [Abstract][Full Text] [Related]  

  • 50. In vivo evaluation of CYP1A2, CYP2A6, NAT-2 and xanthine oxidase activities in a Greek population sample by the RP-HPLC monitoring of caffeine metabolic ratios.
    Begas E; Kouvaras E; Tsakalof A; Papakosta S; Asprodini EK
    Biomed Chromatogr; 2007 Feb; 21(2):190-200. PubMed ID: 17221922
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Detailed modelling of caffeine metabolism and examination of the CYP1A2 gene: lack of a polymorphism in CYP1A2 in Caucasians.
    Welfare MR; Aitkin M; Bassendine MF; Daly AK
    Pharmacogenetics; 1999 Jun; 9(3):367-75. PubMed ID: 10471069
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Coffee consumption, alcohol use, and cigarette smoking as determinants of serum total and HDL cholesterol in two Serbian cohorts of the Seven Countries Study.
    Jansen DF; Nedeljkovic S; Feskens EJ; Ostojic MC; Grujic MZ; Bloemberg BP; Kromhout D
    Arterioscler Thromb Vasc Biol; 1995 Nov; 15(11):1793-7. PubMed ID: 7583557
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Combined effects of well-done red meat, smoking, and rapid N-acetyltransferase 2 and CYP1A2 phenotypes in increasing colorectal cancer risk.
    Le Marchand L; Hankin JH; Wilkens LR; Pierce LM; Franke A; Kolonel LN; Seifried A; Custer LJ; Chang W; Lum-Jones A; Donlon T
    Cancer Epidemiol Biomarkers Prev; 2001 Dec; 10(12):1259-66. PubMed ID: 11751443
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Time response of cytochrome P450 1A2 activity on cessation of heavy smoking.
    Faber MS; Fuhr U
    Clin Pharmacol Ther; 2004 Aug; 76(2):178-84. PubMed ID: 15289794
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Development and validation of a reversed-phase HPLC method for CYP1A2 phenotyping by use of a caffeine metabolite ratio in saliva.
    Begas E; Kouvaras E; Tsakalof AK; Bounitsi M; Asprodini EK
    Biomed Chromatogr; 2015 Nov; 29(11):1657-63. PubMed ID: 25891161
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rifampicin is only a weak inducer of CYP1A2-mediated presystemic and systemic metabolism: studies with tizanidine and caffeine.
    Backman JT; Granfors MT; Neuvonen PJ
    Eur J Clin Pharmacol; 2006 Jun; 62(6):451-61. PubMed ID: 16758262
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effect of sodium tanshinone II A sulfonate on the activity of CYP1A2 in healthy volunteers.
    Chen Y; Tu JH; He YJ; Zhang W; Wang G; Tan ZR; Zhou G; Fan L; Zhou HH
    Xenobiotica; 2009 Jul; 39(7):508-13. PubMed ID: 19534587
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Caffeine induces cytochrome P4501A2: induction of CYP1A2 by tea in rats.
    Chen L; Bondoc FY; Lee MJ; Hussin AH; Thomas PE; Yang CS
    Drug Metab Dispos; 1996 May; 24(5):529-33. PubMed ID: 8723732
    [TBL] [Abstract][Full Text] [Related]  

  • 59. CYP1A2 and coffee intake and the modifying effect of sex, age, and smoking.
    Rodenburg EM; Eijgelsheim M; Geleijnse JM; Amin N; van Duijn CM; Hofman A; Uitterlinden AG; Stricker BH; Visser LE
    Am J Clin Nutr; 2012 Jul; 96(1):182-7. PubMed ID: 22648710
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Phenotyping of CYP1A2 in Japanese population by analysis of caffeine urinary metabolites: absence of mutation prescribing the phenotype in the CYP1A2 gene.
    Nakajima M; Yokoi T; Mizutani M; Shin S; Kadlubar FF; Kamataki T
    Cancer Epidemiol Biomarkers Prev; 1994; 3(5):413-21. PubMed ID: 7920209
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.